Mastelli srl, via Bussana Vecchia, Sanremo, Italy   Report issue

For profit Phase 4
Founded: Sanremo Italy (1952)

Organization Overview

First Clinical Trial
2007
NCT00638872
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Mastelli S.r.l

Active Ingredients

Drugs in Phase 4 Trials (2)

polydeoxyribonucleotide (2 trials)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foot Ulcer (Phase 4)

Scleroderma, Diffuse (Phase 4)

Scleroderma, Localized (Phase 4)

Scleroderma, Systemic (Phase 4)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2